CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Empower Neuromodulation System Transcutaneous Electrical Nerve Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04184362
NCT04184362N/ACompleted
CompareCT.gov

Empower Opioid Misuse Theranova Study for Veterans With Chronic Pain

University of California, San Francisco·interventional·Posted Dec 3, 2019·Updated Aug 3, 2023

In Brief

A clinical study evaluating Empower Neuromodulation System Transcutaneous Electrical Nerve Stimulation for Chronic Pain and Opioid Use. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This study evaluates the effects of peripheral nerve stimulation on opioid craving and use and pain in participants with chronic non-cancer pain (NCP) and opioid misuse. Participants will be randomized to receive the active or sham control treatment for the duration of the study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain, Opioid Use
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 3, 2019
Enrollment StartNov 20, 2019
Primary CompletionMar 21, 2022
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 6.6 years ago

Interventions

Empower Neuromodulation System Transcutaneous Electrical Nerve Stimulationdevice

Participants will self-administer treatment with the Empower device two times daily for two weeks. Participants will complete surveys over the two-week period to evaluate the effects of the Empower treatment.